Literature DB >> 26653697

Isolated pulmonic valve endocarditis presenting as neck pain.

Aditya Goud1, Abdelhai Abdelqader2, Chanukya Dahagam2, Sriram Padmanabhan3.   

Abstract

We discuss a unique case of a 52-year-old man with no history of intravenous drug use or dental procedures who presented with neck pain, 2 weeks of fevers, chills, night sweats, cough, and dyspnea found to have isolated pulmonic valve (PV) endocarditis. The patient did not have an associated murmur, which is commonly seen in right-sided infectious endocarditis. A transthoracic echocardiogram showed a thickened PV leaflet, with subsequent transesophageal echocardiogram showing a PV mass. Speciation of blood cultures revealed Streptococcus oralis. In right-sided infective endocarditis, usually the tricuspid valve is involved; however, in our case the tricuspid valve was free of any mass or vegetation. The patient did meet Duke criteria and was thus started on long-term intravenous antibiotics for infectious endocarditis. The patient's symptoms quickly improved with antibiotics. A careful history and evaluating the patient's risk factors are key in earlier detection of infective endocarditis (IE). Because of early detection and a high index of suspicion, the patient had no further complications and did not require any surgery. In conclusion, clinical suspicion of right-sided IE should be high in patients who present with persistent fevers and pulmonary symptoms in order to reduce the risk of complications, and to improve outcomes.

Entities:  

Keywords:  endocarditis; pulmonic; septic emboli; vegetation

Year:  2015        PMID: 26653697      PMCID: PMC4677583          DOI: 10.3402/jchimp.v5.29647

Source DB:  PubMed          Journal:  J Community Hosp Intern Med Perspect        ISSN: 2000-9666


Isolated pulmonic valve endocarditis (PVE) is a rare event that is commonly associated with intravenous drug use (IVDU) and other risk factors. We present a unique case of a man complaining of neck pain found to have bacteremia with cervical discitis and PVE. We discuss the manifestation of PVE in a patient without common risk factors and its clinical and pathologic associations.

Case report

A 52-year-old man with significant history only of remote non-injection drug use presented with neck pain, 2 weeks of mild fevers, chills, night sweats, unintentional weight loss, dyspnea, and dry cough. On physical examination, he appeared non-toxic with poor dentition. He was febrile with a white cell count of 25,000/µL. Magnetic resonance imaging done for the neck pain was concerning for cervical discitis, while a computed tomography (CT) chest scan done for his pulmonary symptoms was concerning for multiple septic pulmonary emboli. Initial blood cultures grew Gram-positive cocci in chains. Because of concerns of infective endocarditis (IE), ampicillin and ceftriaxone were started. A transthoracic echocardiogram (TTE) showed a thickened pulmonic valve (PV) leaflet with a pulmonary artery systolic pressure of 58 mmHg. A subsequent transesophageal echocardiogram (TEE) revealed a 2-cm, mobile, linear PV mass with moderate, eccentric pulmonic regurgitation (Fig. 1). CT angiogram showed a pulmonary embolism distal to the right main pulmonary artery with distal propagation. Speciation of blood cultures showed pan-sensitive Streptococcus oralis. Meeting Duke criteria for IE, he was discharged on a 6-week course of ceftriaxone via a tunneled catheter. He showed dramatic improvement within a short period and had no further complications. Hence, surgical intervention was deferred. Overall, his prognosis was more promising due to early detection and no ensuing complications. However, the patient was subsequently lost to follow-up.
Fig. 1

Pulmonic valve vegetation seen on TEE (red arrows).

Pulmonic valve vegetation seen on TEE (red arrows).

Discussion

Right-sided infective endocarditis (RSIE) is a rare phenomenon that predominantly involves the tricuspid valve, with or without involvement of the PV. However, isolated PV vegetation is an extremely rare event that typically occurs in 1.5–2% of patients hospitalized with IE (1). From 1960 to 2005, there were only 45 reported cases of PVE in structurally normal hearts (2). Proposed mechanisms for lower incidence of RSIE are attributed to the right heart valves having lower prevalence of congenital malformations, differences in the endothelium and vascularity, lower pressure gradients leading to lower jet velocities and reduced stress on the right-sided endocardium as well as reduced oxygen content in the venous blood (3, 4). Identifying risk factors for RSIE helps heighten clinical suspicion to make an earlier diagnosis, which improves outcomes. Major risk factors are IVDU (76%), congenital cardiac defects, sepsis, alcohol abuse, diabetes, pacemaker, and central venous catheter implantation. In about 28% of the cases no specific risk factor is identified (2, 4–6). In our case, absence of these risk factors made the diagnosis more challenging. Management and subsequent prognosis of this unique entity is determined by early and high diagnostic suspicion. This was particularly difficult in this case because of the dominating extra cardiac signs and symptoms. Presentation of RSIE often mimics primary pulmonary symptoms, such as fevers, dyspnea, and cough, with or without a normal chest x-ray (7). In roughly 50% of reported cases, there was an associated pulmonic regurgitation murmur (8), which was not appreciated in the above patient. A PV thrombus cannot be ruled out; however, our clinical suspicion was high for PV vegetation given our patient's presenting symptoms in addition to the presence of multiple septic emboli. In detecting PV vegetations, TEE has higher sensitivity and specificity in comparison to TTE. Radiographic imaging can often confirm the presence of pulmonary embolism and septic emboli. The most common microbial culprits are Staphylococcus aureus, coagulase-negative Staphylococcus, and Group B Streptococcus, with septic pulmonary emboli being seen in approximately 75% of patients (9–11). In non-complicated cases, initial management (12) should be with antibiotics only, as response is often seen within 6 weeks of therapy (13). A retrospective study has shown that vegetations less than 1–2 cm in RSIE commonly respond to medical treatment (14). Indications for surgery include persistent bacteremia and fevers despite appropriate parenteral antibiotic therapy, recurrent pulmonary emboli, locally invasive infections such as a perivalvular abscess, cardiovascular instability, or progressive valve destruction and incompetence leading to heart failure. Common surgical options may be divided into ‘prosthetic’ – valve replacement or prosthetic annular implantation – and ‘non-prosthetic’ – Kay's or DeVega's annuloplasty, bicuspidization, valvectomy, debridement of the infected area, or excision of the vegetation (12). Overall, the prognosis for RSIE including isolated PVE is generally better than left-sided IE, with the latter carrying a higher mortality rate (15).

Conclusions

We document a rare case of isolated PVE that had a non-specific presentation. Evaluation of the patient's risk factors and a careful history are key in earlier detection of RSIE. This can help reduce hospital-related costs via avoiding complications and even the need for surgery. Hence, high index of suspicion is required as early diagnosis can drastically improve outcomes while avoiding complications and preventing the need for surgery. In our case, prognosis was favorable due to early detection and no ensuing complications.
  15 in total

Review 1.  Pulmonic valve endocarditis.

Authors:  Muhammad Tariq; Raymond A Smego; Adil Soofi; Najmul Islam
Journal:  South Med J       Date:  2003-06       Impact factor: 0.954

2.  Pulmonic valve endocarditis in a normal heart.

Authors:  Rebecca A Schroeder
Journal:  J Am Soc Echocardiogr       Date:  2005-02       Impact factor: 5.251

3.  Pulmonary-valve endocarditis.

Authors:  Nicholas Kang; Warren Smith; Sally Greaves; David Haydock
Journal:  N Engl J Med       Date:  2007-05-24       Impact factor: 91.245

Review 4.  Community acquired staphylococcal pulmonary valve endocarditis in non-drug users: case report and review of the literature.

Authors:  J J Edmond; S J Eykyn; L D Smith
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

5.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

Review 6.  Isolated pulmonic valve endocarditis in healthy hearts: a case report and review of the literature.

Authors:  F B Ramadan; D S Beanlands; I G Burwash
Journal:  Can J Cardiol       Date:  2000-10       Impact factor: 5.223

7.  Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database.

Authors:  José M Miro; Ignasi Anguera; Christopher H Cabell; Anita Y Chen; Judith A Stafford; G Ralph Corey; Lars Olaison; Susannah Eykyn; Bruno Hoen; Elias Abrutyn; Didier Raoult; Arnold Bayer; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2005-07-06       Impact factor: 9.079

8.  Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy--a placebo-controlled, randomized study.

Authors:  M R Cesarone; L Incandela; G Belcaro; M T De Sanctis; A Ricci; M Griffin
Journal:  Angiology       Date:  2001-12       Impact factor: 3.619

9.  Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes.

Authors:  S R Hecht; M Berger
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

Review 10.  Isolated pulmonic valve infective endocarditis: a persistent challenge.

Authors:  N Hamza; J Ortiz; R A Bonomo
Journal:  Infection       Date:  2004-06       Impact factor: 3.553

View more
  5 in total

1.  Whole genome sequencing as a tool for phylogenetic analysis of clinical strains of Mitis group streptococci.

Authors:  L H Rasmussen; R Dargis; K Højholt; J J Christensen; O Skovgaard; U S Justesen; F S Rosenvinge; C Moser; O Lukjancenko; S Rasmussen; X C Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-20       Impact factor: 3.267

2.  Dynamic Course of Serratia marcescens Pulmonic Valve Endocarditis Resulting in Submassive PE and Valve Replacement.

Authors:  Chloe Grace Meyer; Thomas Paul Vacek; Amit Bansal; Ravi Gurujal; Analkumar Parikh
Journal:  J Investig Med High Impact Case Rep       Date:  2018-02-26

3.  Tricuspid insufficiency after cardiac-implantable electronic device placement.

Authors:  Nismat Javed; Raafe Iqbal; Jahanzeb Malik; Ghazanfar Rana; Waheed Akhtar; Syed Muhammad Jawad Zaidi
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-11-15

4.  JCHIMP at 5 years: growth and development.

Authors:  Robert P Ferguson
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-12-11

5.  Multi-organ embolism caused by oscillating aortic valve vegetation: A case report.

Authors:  Guang Huang; Yu Tang; Rong Xiong; Ainan Xu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.